Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

Similar articles for PubMed (Select 9593344)

1.

Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma.

Strobl FJ, Hoffman S, Huber S, Williams EC, Voelkerding KV.

Arch Pathol Lab Med. 1998 May;122(5):430-3.

PMID:
9593344
2.

Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma.

Kapiotis S, Quehenberger P, Jilma B, Handler S, Pabinger-Fasching I, Mannhalter C, Speiser W.

Am J Clin Pathol. 1996 Nov;106(5):588-93.

PMID:
8929467
3.

The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.

Chitolie A, Lawrie AS, Mackie IJ, Harrison P, Machin SJ.

Blood Coagul Fibrinolysis. 2001 Apr;12(3):179-86.

PMID:
11414631
4.

Modified APC-resistance test: variable ratios with respect to source of factor V-deficient plasma.

Ts'ao C, Neofotistos D, Oropeza M, Vahabinejad S, Finn WG.

Am J Hematol. 1997 Mar;54(3):214-8.

PMID:
9067500
5.

Factor V R506Q gene mutation analysis by PCR-RFLP: optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls.

Voelkerding KV, Wu L, Williams EC, Hoffman SM, Sabatini LM, Borcherding WR, Huber S.

Am J Clin Pathol. 1996 Jul;106(1):100-6.

PMID:
8701917
6.
8.

Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.

Quincampoix JC, Legarff M, Rittling C, Andiva S, Toulon P.

Blood Coagul Fibrinolysis. 2001 Oct;12(7):569-76.

PMID:
11685046
9.

The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.

van Oerle R, van Pampus L, Tans G, Rosing J, Hamulyák K.

Am J Clin Pathol. 1997 May;107(5):521-6.

PMID:
9128263
10.

Determination of activated protein C resistance in anticoagulated and lupus positive patients.

Ivey LM, Thom JY, Ivey JG, Baker RI.

Blood Coagul Fibrinolysis. 2000 Jul;11(5):439-45.

PMID:
10937805
11.

Proposal for objective evaluation of the performance of various functional APC-resistance tests in genotyped patients.

Freyburger G, Javorschi S, Labrouche S, Bernard P.

Thromb Haemost. 1997 Nov;78(5):1360-5.

PMID:
9408020
14.
18.

Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.

Dahlbäck B, Zöller B, Hillarp A.

Haemostasis. 1996 Oct;26 Suppl 4:301-14. Review.

PMID:
8979136
19.
20.

Instrument effect on the activated protein C resistance plasma assay performed by a commercial kit.

De Stefano V, Paciaroni K, Mastrangelo S, Rutella S, Bizzi B, Leone G.

Thromb Haemost. 1996 May;75(5):752-6.

PMID:
8725718
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk